Splenic Neoplasms

"Splenic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the SPLEEN.

Descriptor ID	D013160
MeSH Number(s)	C04.588.842 C15.604.744.680
Concept/Terms	Splenic Neoplasms Splenic Neoplasms Neoplasm, Splenic Splenic Neoplasm Neoplasms, Splenic Spleen Neoplasms Neoplasm, Spleen Neoplasms, Spleen Spleen Neoplasm Cancer of Spleen Cancer of Spleen Spleen Cancers Splenic Cancer Cancer, Splenic Cancers, Splenic Splenic Cancers Cancer of the Spleen Spleen Cancer Cancer, Spleen Cancers, Spleen

Below are MeSH descriptors whose meaning is more general than "Splenic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Splenic Neoplasms [C04.588.842]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Splenic Diseases [C15.604.744]
Splenic Neoplasms [C15.604.744.680]

Below are MeSH descriptors whose meaning is more specific than "Splenic Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Splenic Neoplasms" by people in this website by year, and whether "Splenic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 51 publications over 24 distinct years, with a maximum of 5 publications in 2012 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	1	0	1
1993	1	0	1
1995	0	1	1
1996	1	0	1
1997	2	1	3
1999	1	1	2
2001	1	2	3
2002	1	0	1
2004	0	1	1
2005	2	2	4
2006	3	0	3
2007	2	1	3
2008	2	0	2
2009	3	1	4
2010	1	0	1
2011	1	1	2
2012	5	0	5
2013	1	1	2
2014	2	0	2
2015	1	0	1
2016	4	1	5
2017	0	1	1
2018	1	0	1
2019	0	1	1

Below are the most recent publications written about "Splenic Neoplasms" by people in Profiles.

Nia ES, Leung JWT. Solitary palpable breast mass as the initial presentation of clinically silent extramedullary acute myeloid leukemia. Breast J. 2020 02; 26(2):267-268.

View in: PubMed
Yabe M, Miranda RN, Medeiros LJ. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors. Hum Pathol. 2018 04; 74:5-16.

View in: PubMed
Yabe M, Medeiros LJ, Wang SA, Tang G, Bueso-Ramos CE, Jorgensen JL, Bhagat G, Chen W, Li S, Young KH, Miranda RN. Distinguishing Between Hepatosplenic T-cell Lymphoma and ?d T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol. 2017 01; 41(1):82-93.

View in: PubMed
Vega EA, Yamashita S, Shin CY, Kim M, Fleming JB, Katz MH, Raghav KP, Vauthey JN, Lee JE, Conrad C. Laparoscopic Partial Splenectomy for Unknown Primary Cancer: A Stepwise Approach. Ann Surg Oncol. 2017 Apr; 24(4):1134.

View in: PubMed
Yabe M, Medeiros LJ, Daneshbod Y, Davanlou M, Bueso-Ramos CE, Moran EJ, Young KH, Miranda RN. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-a inhibitor therapy and literature review. Ann Diagn Pathol. 2017 Feb; 26:16-22.

View in: PubMed
Rajeshkumar NV, Yabuuchi S, Pai SG, Tong Z, Hou S, Bateman S, Pierce DW, Heise C, Von Hoff DD, Maitra A, Hidalgo M. Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer. Br J Cancer. 2016 08 09; 115(4):442-53.

View in: PubMed
Andtbacka RH, Ross M, Puzanov I, Milhem M, Collichio F, Delman KA, Amatruda T, Zager JS, Cranmer L, Hsueh E, Chen L, Shilkrut M, Kaufman HL. Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial. Ann Surg Oncol. 2016 12; 23(13):4169-4177.

View in: PubMed
Yabe M, Medeiros LJ, Tang G, Wang SA, Ahmed S, Nieto Y, Hu S, Bhagat G, Oki Y, Patel KP, Routbort M, Luthra R, Fanale MA, Bueso-Ramos CE, Jorgensen JL, Vega F, Chen W, Hoehn D, Konoplev S, Milton DR, Wistuba I, Li S, You MJ, Young KH, Miranda RN. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol. 2016 May; 40(5):676-88.

View in: PubMed
Yabe M, Medeiros LJ, Tang G, Wang SA, P Patel K, Routbort M, Bhagat G, Bueso-Ramos CE, Jorgensen JL, Luthra R, Chen W, Muzzafar T, Kanagal-Shamanna R, Khoury JD, Daneshbod Y, Davanlou M, Li S, Young KH, Miranda RN. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Hum Pathol. 2016 Apr; 50:109-17.

View in: PubMed
Ok CY, Yin CC, Yabe M, Bueso-Ramos CE, Miranda RN, Medeiros LJ, Konoplev SN. Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma? Clin Lymphoma Myeloma Leuk. 2014 Jun; 14(3):e95-e100.

View in: PubMed

People

Explore

Similar Concepts

Top Journals